Abstract
Because 5-HT<sub>1A</sub> receptors located on the soma dendrites of serotonin (5-HT) neurons normally mediate an inhibition of 5-HT firing and release, the desensitization of these autoreceptors is essential for obtaining an enhancement of 5-HT transmission after treatment with 5-HT reuptake inhibitors (SSRIs). We have demonstrated previously, using immunoelectron microscopy with specific 5-HT<sub>1A</sub> antibodies, that an internalization of 5-HT<sub>1A</sub> autoreceptors is associated with their desensitization in rats given a single dose of the 5-HT<sub>1A</sub> receptor agonist 8-hydroxy-2-(di-<i>n</i>-propylamino)tetralin. Here, we examined the subcellular distribution of 5-HT<sub>1A</sub> receptors in dendrites from nucleus raphe dorsalis (NRD) (autoreceptors) and hippocampus (heteroreceptors) after acute treatment with the antidepressant SSRI, fluoxetine (10 mg/kg, i.p.). In parallel experiments, the kinetics of <i>in vivo</i> binding of the 5-HT<sub>1A</sub> positron emission tomography radioligand 4,2-(methoxyphenyl)-1-[2-(<i>N</i>-2-pyridinyl)-p-fluorobenzamido]ethylpiperazine ([<sup>18</sup>F]MPPF) was measured in these two brain regions by means of stereotaxically implanted β microprobes. One hour after treatment, there was a 36% decrease in 5-HT<sub>1A</sub> immunogold labeling of the plasma membrane of NRD dendrites, and a concomitant increase in their cytoplasmic labeling, without any change in hippocampal dendrites. <i>In vivo</i> binding of [<sup>18</sup>F]MPPF was reduced by 35% in NRD and unchanged in hippocampus. Both effects were blocked by pretreatment with the 5-HT<sub>1A</sub> receptor antagonist (<i>N</i>-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-<i>N</i>-(2-pyridinyl) cyclohexane-carboxamide) (1 mg/kg, i.p.). In brain sections of NRD and hippocampus, [<sup>18</sup>F]MPPF autoradiographic labeling did not differ between fluoxetine- and saline-treated rats. These immunocytochemical results confirmed that internalization of 5-HT<sub>1A</sub> autoreceptors may account for their desensitization, and the microprobe results suggest that this prerequisite for antidepressant treatment efficacy could be amenable to brain imaging in humans.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.